[1] |
中国抗癌协会妇科肿瘤专业委员会. 妊娠滋养细胞疾病诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6):520-532. doi: 10.19401/j.cnki.1007-3639.2021.06.10.
|
[2] |
谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018:328-331.
|
[3] |
王丽娟, 王东雁, 林仲秋. 《2024 NCCN妊娠滋养细胞肿瘤临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2023, 39(12):1217-1224. doi: 10.19538/j.fk2023120115.
|
[4] |
冯向芝, 向阳. 上皮样滋养细胞肿瘤的研究进展[J]. 中华妇产科杂志, 2003, 38(12):773-775. doi: 10.3760/j.issn:0529-567X.2003.12.019.
|
[5] |
Lee KW, Ho LC. A case of massive fetomaternal haemorrhage at term associated with choriocarcinoma[J]. Aust N Z J Obstet Gynaecol, 1999, 39(2):274-276. doi: 10.1111/j.1479-828x.1999.tb03394.x.
|
[6] |
Ngan H, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease[J]. Int J Gynaecol Obstet, 2018, 143 (Suppl 2):79-85. doi: 10.1002/ijgo.12615.
|
[7] |
毛铭懿, 蒋芳, 向阳. 高危耐药及复发妊娠滋养细胞肿瘤诊疗现状[J]. 协和医学杂志, 2024. doi: 10.12290/xhyxzz.2024-0135.
|
[8] |
林劲楷. 初治妊娠滋养细胞肿瘤的预后评分系统优化[D]. 北京: 北京协和医学院, 2023.
|
[9] |
华晓萍, 吕卫国. 美国国家综合癌症网络妊娠滋养细胞肿瘤临床实践指南(2023年第1版)解读[J]. 实用妇产科杂志, 2023, 39(4):264-267.
|
[10] |
Sebire NJ, Lindsay I, Fisher RA, et al. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma[J]. Fetal Pediatr Pathol, 2005, 24(1):21-29. doi: 10.1080/15227950590961180.
pmid: 16175749
|
[11] |
Liu J, Guo L. Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature[J]. Gynecol Oncol, 2006, 103(3):1147-1151. doi: 10.1016/j.ygyno.2006.08.007.
pmid: 17005243
|
[12] |
Lewis NE, Marszalek L, Ernst LM. Placental Pathologic Features in Fetomaternal Hemorrhage Detected By Flow Cytometry[J]. Pediatr Dev Pathol, 2017, 20(2):142-151. doi: 10.1177/1093526616687652.
|
[13] |
Nomura RM, Ferreira MV, Latif IO, et al. Agreement between maternal perception of fetal movements and visualization by ultrasound[J]. Rev Bras Ginecol Obstet, 2013, 35(2):55-59. doi: 10.1590/s0100-72032013000200003.
|